REVELATION BIOSCIENCES, INC. Stock Split Ratio
REVELATION BIOSCIENCES, INC. (REVB) had Stock Split Ratio of 0.25% as of 2026-01-28, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2026-08-06
- 2026-01-28: Stockholders' Equity Note, Stock Split, Conversion Ratio 0.25%.
- 2025-07-07: Stockholders' Equity Note, Stock Split, Conversion Ratio 0.33%.
- 2025-01-28: Stockholders' Equity Note, Stock Split, Conversion Ratio 0.06%.
- 2024-01-25: Stockholders' Equity Note, Stock Split, Conversion Ratio 0.03%; Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed 3.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed |
|---|---|---|
| 2026-01-28 | 0.25% 10-Q · filed 2026-08-06 | |
| 2025-07-07 | 0.33% 10-Q · filed 2026-08-06 | |
| 2025-01-28 | 0.06% 10-Q · filed 2026-08-06 | |
| 2024-01-25 | 0.03% 10-K · filed 2026-02-26 | 3.00% 10-Q · filed 2024-05-10 |
| 2024-01-22 | 0.03% 10-K · filed 2025-03-06 | |
| 2023-02-01 | 2.00% 10-K/A · filed 2024-09-23 | 3.00% 10-Q · filed 2023-05-22 |
| 2023-01-30 | 3.00% 10-K/A · filed 2024-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |